Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 15 Squamous Cell Carcinoma of Head and Neck 11 Small Cell Lung Carcinoma 9 Lung Neoplasms 9 Oropharyngeal Neoplasms 7 Mouth Neoplasms 6 Laryngeal Neoplasms 6 Carcinoma 6 Uterine Cervical Neoplasms 5 Urinary Bladder Neoplasms 5 Stomach Neoplasms 4 Hypopharyngeal Neoplasms 4 Breast Neoplasms 4 Adenocarcinoma of Lung 4 Pancreatic Neoplasms 3 Nasopharyngeal Carcinoma 3 Brain Neoplasms 3 Vulvar Neoplasms 2 Salivary Gland Neoplasms 2 Recurrence 2 Paranasal Sinus Neoplasms 2 Ovarian Neoplasms 2 Medulloblastoma 2 Lymphoid Interstitial Pneumonia 2 Liver Neoplasms 2 Head and Neck Neoplasms 2 Fallopian Tube Neoplasms 2 Cholangiocarcinoma 2 Anus Neoplasms 2 Urethral Neoplasms 1

Interventions

Temozolomide 154 Bevacizumab 88 Radiotherapy 75 Radiation 23 Magnetic Resonance Spectroscopy 23 Lomustine 18 Irinotecan 18 pembrolizumab 17 Surgical Procedures, Operative 16 Carmustine 16 Erlotinib Hydrochloride 12 Nivolumab 11 Specimen Handling 10 Aminolevulinic Acid 10 sargramostim 9 Thalidomide 9 Chemotherapy, Adjuvant 9 Carboplatin 9 Drug Therapy 8 Immunoglobulin G 7 Filgrastim 7 Etoposide 7 Disulfides 7 Cilengitide 7 Sunitinib 6 Sorafenib 6 O(6)-benzylguanine 6 Cyclophosphamide 6 antineoplaston AS 2-1 5 antineoplaston A10 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Glioblastoma × Platinum × Clear all

NCT07138001 2025-08-22

Phase 2 Clinical Trial of KH617

Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Phase 2 Not yet recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡